US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

CAR-T Concept

1,483.73

-9.5389-0.64%

Number of Gainers:- -

Number of Losers:2

Number of Flat:- -

PE:- -

High:1,495.08

Open:1,491.89

Low:1,481.54

Close:1,493.01

Volume:1.42M

Turnover:165.71M

Market Cap:385.74B

Float Cap:373.87B

Loading ...

Gilead Sciences Inc. CFO Andrew D. Dickinson Reports Disposal of Common Shares

Gilead Sciences (GILD) Gets a Buy from Mizuho Securities

Novartis AG China's Chen Hui: Only Pharmacies with Specialized Service Capabilities Can Navigate Future Cycles

Gilead Sciences Inc. Appoints Erin Burkhart as Senior Vice President and Principal Accounting Officer

BRIEF-Mubadala Reports Stake in Disney and Merck, Dissolves Stake in Comcast

Novartis, Roche Reportedly Meet With Swiss Government Over US Tariffs

MT Newswires Live

Why the Highest-Yielding Vanguard ETF Might Not Be the Best one to Own

GILD Q2 Deep Dive: HIV Franchise Drives Growth, New Launches and Pipeline in Focus

stock_story_highlight

Sector Update: Health Care Stocks Rise Late Afternoon

MT Newswires Live

Market Chatter: Novartis, Roche Executives to Meet With Swiss Government About US Tariffs

MT Newswires Live

Sector Update: Health Care Stocks Rise Premarket Monday

MT Newswires Live

Rheinmetall, Ørsted, Novartis: Global Stocks in Focus -- WSJ

Novartis announces both ianalumab trials met primary endpoint

Novartis's Trial Results Suggest Pipeline in a Pill Could Be Under Way -- Market Talk

Analysts Offer Insights on Healthcare Companies: Omada Health, Inc. (OMDA), Gilead Sciences (GILD) and Cytokinetics (CYTK)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK4578/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4578","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4578\",,,,,undefined,":{"symbol":"BK4578","market":"US","secType":"PLATE","nameCN":"CAR-T Concept","latestPrice":1483.471,"timestamp":1756136362107,"preClose":1493.0099,"halted":0,"volume":1417984,"delay":0,"changeRate":-0.006389,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-9.53894,"latestTime":"08-25 11:39:24 EDT","open":1491.8932,"high":1495.0787,"low":1481.5449,"amount":165714046.742086,"amplitude":0.009065,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1756152000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":6.300111,"peRate":19.456977,"turnoverRate":0.00046,"increases":0,"decrements":2,"flats":0,"marketCap":385741684736,"floatMarketCap":373873131520},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4578\",,,,,undefined,":{"symbol":"BK4578","high":1495.0787,"amplitude":0.009065,"preClose":1493.0099,"low":1481.5449,"pbRate":"6.300111","latestPrice":1483.7286,"volume":1419103,"delay":0,"open":1491.8932,"prevYearClose":1164.883,"prevWeekClose":1493.0099,"prevMonthClose":1382.28,"prevQuarterClose":1430.2296,"fiveDayClose":1485.8917,"twentyDayClose":1404.2614,"sixtyDayClose":1367.9299,"secType":"PLATE","market":"US","turnoverRate":0.00046,"peRate":19.456977,"marketCap":385741684736,"floatMarketCap":373873131520,"timestamp":1756136366848,"nameCN":"CAR-T Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4578\",,,,undefined,":{"bkCode":"BK4578","up":0,"down":2,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4578\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2560134880","title":"Gilead Sciences Inc. CFO Andrew D. Dickinson Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2560134880","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560134880?lang=en_us&edition=fundamental","pubTime":"2025-08-19 07:34","pubTimestamp":1755560078,"startTime":"0","endTime":"0","summary":"Andrew D. Dickinson, Chief Financial Officer of Gilead Sciences Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gilead Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 18, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250818:nNDLbgdh4p:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1571399168.USD","IE0002270589.USD","LU2324357040.USD","BK4532","IE00BZ1G4Q59.USD","GILD","LU0320765992.SGD","SG9999015952.SGD","LU0234570918.USD","BK4583","LU1585245621.USD","SG9999015945.SGD","BK4566","IE00B19Z3B42.SGD","LU0058720904.USD","LU0889565916.HKD","BK4550","SG9999015986.USD","IE00B7SZLL34.SGD","LU1778281490.HKD","IE00BKVL7J92.USD","LU1674673691.USD","LU1430594728.SGD","LU1674673428.USD","BK4139","LU1066051498.USD","SG9999015978.USD","LU1839511570.USD","IE00B3T34201.USD","BK4578","BK4568","BK4585","IE00B19Z3581.USD","LU0109394709.USD","LU1066053197.SGD","BK4588","LU0289739699.SGD","LU2087621335.USD","LU0823416689.USD","IE00BSNM7G36.USD","LU2089984988.USD","LU2468319806.SGD"],"gpt_icon":0},{"id":"2560183024","title":"Gilead Sciences (GILD) Gets a Buy from Mizuho Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2560183024","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560183024?lang=en_us&edition=fundamental","pubTime":"2025-08-18 21:55","pubTimestamp":1755525306,"startTime":"0","endTime":"0","summary":"In a report released today, Salim Syed from Mizuho Securities maintained a Buy rating on Gilead Sciences, with a price target of $131.00. The compa...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/gilead-sciences-gild-gets-a-buy-from-mizuho-securities-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/gilead-sciences-gild-gets-a-buy-from-mizuho-securities-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4566","LU1430594728.SGD","SG9999015986.USD","LU2468319806.SGD","BK4207","IE00B3T34201.USD","SG9999015945.SGD","LU1066053197.SGD","IE0002270589.USD","SG9999015978.USD","BK4578","IE00B19Z3B42.SGD","LU0058720904.USD","LU0289739699.SGD","IE00BSNM7G36.USD","IE00BZ1G4Q59.USD","LU0234570918.USD","BK4583","LU1674673428.USD","BK4532","LU2087621335.USD","LU2324357040.USD","LU1571399168.USD","GILD","LU0889565916.HKD","SG9999015952.SGD","LU1585245621.USD","MFG","BK4550","IE00B7SZLL34.SGD","IE00BKVL7J92.USD","LU1839511570.USD","LU1066051498.USD","LU1674673691.USD","BK4568","LU2089984988.USD","BK4585","LU0823416689.USD","IE00B19Z3581.USD","LU1778281490.HKD","BK4139","LU0109394709.USD","BK4588","LU0320765992.SGD"],"gpt_icon":0},{"id":"1166287297","title":"Novartis AG China's Chen Hui: Only Pharmacies with Specialized Service Capabilities Can Navigate Future Cycles","url":"https://stock-news.laohu8.com/highlight/detail?id=1166287297","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166287297?lang=en_us&edition=fundamental","pubTime":"2025-08-17 18:00","pubTimestamp":1755424825,"startTime":"0","endTime":"0","summary":"The 18th West China Pharmaceutical Health Industry Conference was held in Boao, Hainan from August 16 to 21, with the theme \"Rapid Transformation, Navigating New Cycles - Reconstructing Growth...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4578","IE0009355771.USD","LU0320765489.SGD","BK4588","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","LU0211331839.USD","BK4532","LU0208291251.USD","IE00B4R5TH58.HKD","LU0070302665.USD","IE00BJT1NW94.SGD","NVS","IE0002141913.USD","BK4585","BK4007","IE00BJJMRZ35.SGD"],"gpt_icon":0},{"id":"2559589964","title":"Gilead Sciences Inc. Appoints Erin Burkhart as Senior Vice President and Principal Accounting Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2559589964","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559589964?lang=en_us&edition=fundamental","pubTime":"2025-08-15 04:17","pubTimestamp":1755202668,"startTime":"0","endTime":"0","summary":"Gilead Sciences Inc. has announced the appointment of Erin Burkhart as Senior Vice President, Controllership, and principal accounting officer, effective September 22, 2025. Burkhart joins Gilead from BioMarin Pharmaceutical Inc., where she has served as Group Vice President and Chief Accounting Officer since May 2022. She will succeed Diane E. Wilfong, who will step down from her interim role as Controller and principal accounting officer.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gilead Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 14, 2025, and is solely res","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nNDL7mdLtM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","IE00BZ1G4Q59.USD","GILD","SG9999015978.USD","LU0109394709.USD","LU1778281490.HKD","IE00B19Z3581.USD","LU0889565916.HKD","LU2089984988.USD","BK4139","BK4583","IE00B19Z3B42.SGD","LU0320765992.SGD","LU1066053197.SGD","BK4578","LU0823416689.USD","LU1066051498.USD","BK4585","IE0002270589.USD","LU1571399168.USD","SG9999015945.SGD","LU2324357040.USD","BK4568","LU0289739699.SGD","SG9999015952.SGD","LU1674673428.USD","LU0058720904.USD","LU2468319806.SGD","LU1674673691.USD","IE00BKVL7J92.USD","LU2087621335.USD","IE00BSNM7G36.USD","BMRN","BK4566","LU1839511570.USD","LU1585245621.USD","IE00B3T34201.USD","LU1430594728.SGD","LU0234570918.USD","IE00B7SZLL34.SGD","SG9999015986.USD","BK4588","BK4550"],"gpt_icon":0},{"id":"2559963024","title":"BRIEF-Mubadala Reports Stake in Disney and Merck, Dissolves Stake in Comcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2559963024","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559963024?lang=en_us&edition=fundamental","pubTime":"2025-08-14 23:54","pubTimestamp":1755186887,"startTime":"0","endTime":"0","summary":"BRIEF-Mubadala Reports Stake in Disney and Merck, Dissolves Stake in ComcastAug 14 (Reuters) - MUBADALA INVESTMENT CO PJSC :REPORTS SHARE STAKE OF 39,400 SHARES IN DISNEY- SEC FILINGREPORTS SHARE STAK","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nFWN3U612N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMCSA","IE00BGHQF748.EUR","LU0251131958.USD","LU0861579265.USD","STT","LU0965509283.SGD","LU0068578508.USD","LU0289739699.SGD","STX","LU0265550946.USD","BK4100","LU2106854487.HKD","SG9999001176.USD","VAC","IE00BFTCPJ56.SGD","LU2265009873.SGD","BK4550","BK4581","TPR","LU1059921491.USD","BK4578","BK4534","IE00BZ1G4Q59.USD","LU1280957306.USD","HPE","MRK","LU0130102774.USD","BK4559","LU0878866978.SGD","DIS","LU1989772840.SGD","GLW","CVS","LU0128525689.USD","LU1934455277.USD","IE00B64PRP62.GBP","LU1548497426.USD","LU0265550359.USD","LU0052756011.USD","LU1291159041.SGD","IE00B19Z9Z06.USD","LU0306807586.USD","LU1974910355.USD","LHX","LU1069347547.HKD","LU1989771016.USD","LU1037948897.HKD","IE00B3QW5Z07.USD","LU2461242641.AUD","GILD"],"gpt_icon":0},{"id":"2559595205","title":"Novartis, Roche Reportedly Meet With Swiss Government Over US Tariffs","url":"https://stock-news.laohu8.com/highlight/detail?id=2559595205","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559595205?lang=en_us&edition=fundamental","pubTime":"2025-08-14 20:41","pubTimestamp":1755175318,"startTime":"0","endTime":"0","summary":"Novartis (NVS) and Roche executives met with Swiss government officials to discuss the outlook for the pharmaceutical industry following the imposition of additional 39% tariff on Swiss exports to the","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","BK4588","BK4532","IE00BFTCPJ56.SGD","LU0320765489.SGD","LU0208291251.USD","LU0070302665.USD","LU0211331839.USD","IE00B2B36J28.USD","BK4007","IE00B4R5TH58.HKD","BK4578","IE0002141913.USD","NVS","IE0009355771.USD","BK4585"],"gpt_icon":0},{"id":"2559952332","title":"Why the Highest-Yielding Vanguard ETF Might Not Be the Best one to Own","url":"https://stock-news.laohu8.com/highlight/detail?id=2559952332","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559952332?lang=en_us&edition=fundamental","pubTime":"2025-08-14 20:03","pubTimestamp":1755172980,"startTime":"0","endTime":"0","summary":"Vanguard has 97 ETFs, most of which pay dividends. Which is best for you?","market":"fut","thumbnail":"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F824319%2Fworld-map-2024.jpg&op=resize&w=165&h=104","type":0,"news_type":0,"thumbnails":["https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F824319%2Fworld-map-2024.jpg&op=resize&w=165&h=104"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/08/14/why-the-highest-yielding-vanguard-etf-might-not-be/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["IE00B4R5TH58.HKD","US10Y.BOND","TM","LU0070302665.USD","BK4007","BK4604","BK4099","IE00BJT1NW94.SGD","US3Y.BOND","03160","BK4578","BK4550","BK4585","FDN","US12M.BOND","IE00BFTCPJ56.SGD","IE0002141913.USD","LU0320765489.SGD","IE0009355771.USD","US5Y.BOND","NVS","US2Y.BOND","LU0211331839.USD","BK4555","US7Y.BOND","US30Y.BOND","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","LU0208291251.USD","BK4532","BK4588","US6M.BOND"],"gpt_icon":0},{"id":"2558649362","title":"GILD Q2 Deep Dive: HIV Franchise Drives Growth, New Launches and Pipeline in Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2558649362","media":"stock_story_highlight","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558649362?lang=en_us&edition=fundamental","pubTime":"2025-08-12 15:29","pubTimestamp":1754983740,"startTime":"0","endTime":"0","summary":"Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 1.8% year on year to $7.08 billion. On the other hand, the company’s full-year revenue guidance of $28.5 billion at the midpoint came in 0.8% below analysts’ estimates. Its non-GAAP profit of $2.01 per share was 2.7% above analysts’ consensus estimates.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stockstory.org/us/stocks/nasdaq/gild/news/earnings-call/gild-q2-deep-dive-hiv-franchise-drives-growth-new-launches-and-pipeline-in-focus","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_story_highlight","symbols":["BK4583","LU1066053197.SGD","LU0889565916.HKD","GILD","SG9999015978.USD","LU0320765992.SGD","LU1778281490.HKD","IE00B3T34201.USD","LU1066051498.USD","IE0002270589.USD","BK4585","LU1571399168.USD","LU2324357040.USD","BK4532","LU1674673691.USD","LU0058720904.USD","IE00BZ1G4Q59.USD","LU0234570918.USD","BK4588","BK4568","IE00B19Z3581.USD","LU0289739699.SGD","BK4139","LU1674673428.USD","BK4550","IE00BKVL7J92.USD","LU1430594728.SGD","LU1585245621.USD","SG9999015945.SGD","LU0109394709.USD","LU2089984988.USD","BK4566","BK4578","IE00B19Z3B42.SGD","LU0823416689.USD","LU1839511570.USD","SG9999015952.SGD","LU2468319806.SGD","IE00BSNM7G36.USD","IE00B7SZLL34.SGD","SG9999015986.USD","LU2087621335.USD"],"gpt_icon":0},{"id":"2558836660","title":"Sector Update: Health Care Stocks Rise Late Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2558836660","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558836660?lang=en_us&edition=fundamental","pubTime":"2025-08-12 03:52","pubTimestamp":1754941975,"startTime":"0","endTime":"0","summary":"Health care stocks increased late Monday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund  each adding 0.2%.The iShares Biotechnology ETF  was shedding 0.3%.In corporate news, Viatris  shares rose 2.6% after it said Monday that the US Food and Drug Administration approved its iron sucrose injection to treat iron deficiency anemia in adult and pediatric patients with chronic kidney disease.Novartis  and Roche executives are due to meet with Swiss government officials this week as President Donald Trump urges pharmaceutical firms to lower their prices in the US, Reuters reported. Economy Minister Guy Parmelin and Health Minister Elizabeth Baume-Schneider will meet with executives of the two drug makers as well as other companies, the  report said. Novartis shares gained 1.2%.Avantor  said Monday that its board remains committed to driving growth, expanding margins and creating sustained shareholder value in response to activist investor Engine Capita","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE0002141913.USD","LU0070302665.USD","LU2065731478.USD","IE00BFTCPJ56.SGD","BK4196","LU2087621335.USD","LU0208291251.USD","IE0009355771.USD","IE00B4R5TH58.HKD","LU0320765489.SGD","BK4585","VTRS","BK4588","BK4007","BK4532","BK4578","LU0211331839.USD","NVS","IE00B2B36J28.USD","RDNT","IE00BJJMRZ35.SGD","BK4583","AVTR","LU1839511570.USD","BK4581","IE00BJT1NW94.SGD","IBB","BK4121","XLV"],"gpt_icon":0},{"id":"2558662202","title":"Market Chatter: Novartis, Roche Executives to Meet With Swiss Government About US Tariffs","url":"https://stock-news.laohu8.com/highlight/detail?id=2558662202","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558662202?lang=en_us&edition=fundamental","pubTime":"2025-08-12 02:29","pubTimestamp":1754936947,"startTime":"0","endTime":"0","summary":"Novartis  and Roche executives are due to meet with Swiss government officials this week as President Donald Trump urges pharmaceutical firms to lower their prices in the US, Reuters reported Monday, citing two sources.Economy Minister Guy Parmelin and Health Minister Elizabeth Baume-Schneider will meet with executives of the two drug makers as well as other companies, the sources told the news outlet.Switzerland is aiming to negotiate with the US to lower the 39% tariffs announced on its exports, according to the report.The discussions may also be about encouraging the drug makers to invest more in the US and reduce Switzerland's trade surplus with the country, which could help lower the tariffs, a source familiar with the matter told Reuters.Novartis and Roche did not immediately reply to requests for comment from MT Newswires.Price: 117.82, Change: +0.97, Percent Change: +0.83","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4578","IE00BJJMRZ35.SGD","LU0070302665.USD","IE00B2B36J28.USD","LU0208291251.USD","LU0320765489.SGD","IE0002141913.USD","IE0009355771.USD","IE00B4R5TH58.HKD","LU0211331839.USD","NVS","IE00BJT1NW94.SGD","BK4532","IE00BFTCPJ56.SGD","BK4585","BK4007","BK4588"],"gpt_icon":0},{"id":"2558663416","title":"Sector Update: Health Care Stocks Rise Premarket Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2558663416","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558663416?lang=en_us&edition=fundamental","pubTime":"2025-08-11 21:15","pubTimestamp":1754918114,"startTime":"0","endTime":"0","summary":"Health care stocks were rising premarket Monday, with The Health Care Select Sector SPDR Fund  and iShares Biotechnology ETF  0.3% higher.RadNet  stock was up more than 7% after the company posted higher Q2 adjusted earnings and service revenue.Legend Biotech  shares were more than 2% higher after the company reported that it swung to Q2 adjusted earnings as revenue increased during the period.Novartis  shares were up more than 1% after the company said two phase III trials assessing ianalumab in adults with active Sjogren's disease met the primary endpoint of showing \"statistically significant\" improvements in disease activity.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0320765489.SGD","BK4532","IE00B2B36J28.USD","IE0002141913.USD","LU0070302665.USD","BK4505","IBB","LU0211331839.USD","IE0009355771.USD","IE00B4R5TH58.HKD","BK4007","XLV","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","BK4139","LU0208291251.USD","RDNT","LU2065731478.USD","NVS","BK4578","BK4588","LEGN","BK4196","BK4585","IE00BJT1NW94.SGD","BK4581"],"gpt_icon":0},{"id":"2558540466","title":"Rheinmetall, Ørsted, Novartis: Global Stocks in Focus -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2558540466","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558540466?lang=en_us&edition=fundamental","pubTime":"2025-08-11 19:16","pubTimestamp":1754910960,"startTime":"0","endTime":"0","summary":"Rheinmetall , Saab : European defense stocks dropped ahead of a meeting later this week between President Trump and Russian President Vladimir Putin to discuss proposals for a Ukraine cease-fire.CATL : The world's largest electric-vehicle battery maker suspended a major lithium mining project. The stock gained 2.3% in Hong Kong. Shares in Chinese lithium producers and South Korean battery makers also rose.Longfor : Chinese property stocks advanced after Beijing eased restrictions on home purchases in suburban areas. Longfor shares gained 2% in Hong Kong.Novartis : The drugmaker's candidate treatment for the autoimmune disorder Sjgren's disease met a key goal in late trials. Shares rose nearly 3% in Switzerland.rsted : The Danish renewable-energy company halted plans to sell a stake in a U.S. offshore wind project and proposed a $9.4 billion rights issue. Shares slid by around one-quarter.This item is part of a Wall Street Journal live coverage event. The full stream can be found by sea","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4578","IE0009355771.USD","LU0320765489.SGD","BK4588","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","LU0211331839.USD","BK4532","LU0208291251.USD","IE00B4R5TH58.HKD","LU0070302665.USD","IE00BJT1NW94.SGD","NVS","IE0002141913.USD","BK4585","BK4007","IE00BJJMRZ35.SGD"],"gpt_icon":0},{"id":"2558559486","title":"Novartis announces both ianalumab trials met primary endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2558559486","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558559486?lang=en_us&edition=fundamental","pubTime":"2025-08-11 17:35","pubTimestamp":1754904924,"startTime":"0","endTime":"0","summary":"Novartis (NVS) announced top-line results from its Phase III trials evaluating ianalumab in adults with active Sjogren’s disease. Both trials met t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novartis-announces-both-ianalumab-trials-met-primary-endpoint-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novartis-announces-both-ianalumab-trials-met-primary-endpoint-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","BK4588","BK4532","IE00BFTCPJ56.SGD","LU0320765489.SGD","LU0208291251.USD","LU0070302665.USD","LU0211331839.USD","IE00B2B36J28.USD","BK4007","IE00B4R5TH58.HKD","BK4578","IE0002141913.USD","NVS","IE0009355771.USD","BK4585"],"gpt_icon":0},{"id":"2558763759","title":"Novartis's Trial Results Suggest Pipeline in a Pill Could Be Under Way -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2558763759","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558763759?lang=en_us&edition=fundamental","pubTime":"2025-08-11 15:18","pubTimestamp":1754896680,"startTime":"0","endTime":"0","summary":"0718 GMT - Novartis's trial results for its ianalumab drug candidate in autoimmune disorder Sjoegren's disease suggests the company's next pipeline in a pill--or a drug marketed for multiple indications--could be under way, Vontobel's Stefan Schneider says in a research note. The Swiss pharmaceutical company said it is testing the drug in other diseases. Ianalumab worked in two late-stage trials and this could pave the way for a systematic treatment for a disease for which there are only limited symptomatic treatments available at the moment, the analyst says. This could increase the diagnosis rate, as the scientific literature estimates 50% of patients are undiagnosed, the analyst says. Vontobel estimates peak sales for the drug at $1 billion. Novartis shares rise 2.3%. ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","BK4588","LU0211331839.USD","LU0208291251.USD","BK4007","BK4578","IE0009355771.USD","IE00BJJMRZ35.SGD","LU0320765489.SGD","LU0070302665.USD","NVS","IE00B4R5TH58.HKD","IE00B2B36J28.USD","BK4585","IE00BJT1NW94.SGD","BK4532","IE0002141913.USD"],"gpt_icon":0},{"id":"2558634363","title":"Analysts Offer Insights on Healthcare Companies: Omada Health, Inc. (OMDA), Gilead Sciences (GILD) and Cytokinetics (CYTK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2558634363","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558634363?lang=en_us&edition=fundamental","pubTime":"2025-08-11 14:30","pubTimestamp":1754893839,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Omada Health, Inc. (OMDA – Research Report), Gilead ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-omada-health-inc-omda-gilead-sciences-gild-and-cytokinetics-cytk-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-omada-health-inc-omda-gilead-sciences-gild-and-cytokinetics-cytk-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0289739699.SGD","IE00B3T34201.USD","HCSG","CYTK","BK4505","LU1571399168.USD","BK4568","LU1778281490.HKD","LU2468319806.SGD","LU0823416689.USD","LU2087621335.USD","LU1674673691.USD","LU0058720904.USD","GILD","BK4588","LU1430594728.SGD","IE00B19Z3581.USD","SG9999015986.USD","IE00B19Z3B42.SGD","LU1066053197.SGD","LU2324357040.USD","LU2089984988.USD","LU1839511570.USD","LU0234570918.USD","LU1066051498.USD","BK4585","BK4196","BK4578","LU1585245621.USD","LU0109394709.USD","BK4566","BK4139","BK4532","BK4550","IE00B7SZLL34.SGD","SG9999015978.USD","IE00BKVL7J92.USD","LU1674673428.USD","BK4583","LU0889565916.HKD","SG9999015945.SGD","IE00BSNM7G36.USD","OMDA","LU0320765992.SGD","SG9999015952.SGD","IE00BZ1G4Q59.USD","IE0002270589.USD","BK4137"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":35,"code":"91000000","status":"200"}]}}